Discover open access scientific publications

Search, annotate, share and cite publications

Publications in Molecular Medicine

P33. NK-92 Cellular Immunotherapy as an Alternative to Donor Derived Peripheral Blood NK Cells

Journal for ImmunoTherapy of Cancer
OncologyMolecular MedicinePharmacologyCancer ResearchAllergyImmunology
2014English

Circulating Immune Cells in Patients With Surgically Resected Nonfunctional Pancreatic Neuroendocrine Tumors

Journal for ImmunoTherapy of Cancer
OncologyMolecular MedicinePharmacologyCancer ResearchAllergyImmunology
2015English

Effect of Age and Cancer on Peripheral Immune Cell Subsets and Their PD-1 and PD-L1 Expression

Journal for ImmunoTherapy of Cancer
OncologyMolecular MedicinePharmacologyCancer ResearchAllergyImmunology
2015English

Severe Cytokine Release Syndrome Resulting in Purpura Fulminans Despite Successful Response to Nivolumab Therapy in a Patient With Pleomorphic Carcinoma of the Lung: A Case Report

Journal for ImmunoTherapy of Cancer
OncologyMolecular MedicinePharmacologyCancer ResearchAllergyImmunology
2019English

Induction and Isolation of Tumor Antigen-Specific CD4+ T Lymphocytes Using Sorting Signal Directed MHC Class-Ii Expression

Journal for ImmunoTherapy of Cancer
OncologyMolecular MedicinePharmacologyCancer ResearchAllergyImmunology
2013English

NGS Technology Applied to Melanoma Cell Lines

Journal for ImmunoTherapy of Cancer
OncologyMolecular MedicinePharmacologyCancer ResearchAllergyImmunology
2013English

Long-Term Survival in Unfavourable-Risk mRCC Patients After Intratumoral Administration of a Cell-Based Allogeneic Vaccine

Journal for ImmunoTherapy of Cancer
OncologyMolecular MedicinePharmacologyCancer ResearchAllergyImmunology
2015English

Cell-Selective Oligonucleotide STAT3 Inhibitor for Immunotherapy of Human Acute Myeloid Leukemia

Journal for ImmunoTherapy of Cancer
OncologyMolecular MedicinePharmacologyCancer ResearchAllergyImmunology
2015English

Preclinical Testing of a Novel Personalized Cancer Vaccine for All Solid Tumors and All Patients

Journal for ImmunoTherapy of Cancer
OncologyMolecular MedicinePharmacologyCancer ResearchAllergyImmunology
2015English

Targeting the TGFβ Pathway With Galunisertib, a TGFβRI SMI, Promotes Anti-Tumor Immunity Leading to Durable, Complete Responses, as Monotherapy and in Combination With Checkpoint Inhibition

Journal for ImmunoTherapy of Cancer
OncologyMolecular MedicinePharmacologyCancer ResearchAllergyImmunology
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy